Your browser doesn't support javascript.
Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective
Advances in Traditional Medicine ; 23(1):85-96, 2023.
Article in English | EMBASE | ID: covidwho-2275040
ABSTRACT
The search for a potent anti-coronavirus therapy for severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2) remains an overwhelming task since the outbreak of COVID-19. It is more evident that most of the existing antiviral and immune-boosting drugs are non-promising and ineffective for the treatment of coronavirus infected patients while the safety of a few drugs/vaccines that have demonstrated high potential remains unclear. With daily records of confirmed infectious cases across the world, it is crucial to emphasize the need for repurposed therapies with a validated ethnomedicinal base focused on well-known active medicines with traceable biochemical, pharmacological and safety profiles for viral infection management. In the present study, recent literature on Artemisia and Artemisia-based products for the management of COVID-19 are reviewed. Artemisia-based products have demonstrated a broad spectrum of biological ability including antiviral properties. Besides its antiviral activity, Artemisia annua have shown to contain appreciable amounts of minerals such as zinc, gallium and selenium among others. Graphic abstract [Figure not available see fulltext.].Copyright © 2021, Institute of Korean Medicine, Kyung Hee University.
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: Advances in Traditional Medicine Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: Advances in Traditional Medicine Year: 2023 Document Type: Article